Dying from Dementia, Suffering Often Unnecessary
This discussion and research on Dying with Dementia and the unnecessary care that often accompanies the late stages of dementia is worth discussing and considering.ByAlzheimer's Reading RoomThis topic is often overlooked and avoided until it is too late.I believe these issues should be considered, and when possible,discussed in support groups. This information is worth sharing and discussing with family members.Learn More -Coping with Alzheimer'sSince individuals with advanceddementia cannot report their symptoms, these symptoms often are untreated, leaving them vulnerable to pain, difficulty breathing and various other conditions.We shouldn't allow these people to suffer. We should be providingpalliative care to make them more comfortable in the time they have left. Topic -Hospice Care, Palliative CareAs a teenager, I had the unfortunate but ultimately career-shaping experience of watching my maternal grandmother decline from Alzheimer's disease. She resided in a nursing home, where her final months were marked by repeated courses of antibiotics for infections and the use of restraints or medications to control her agitation before she died from one last infection. Seeing my grandmother in that state was so distressing that my mother eventually stopped taking the grandchildren to visit. My grandmother had little in the way of either comfort or company toward the end. ~Greg A. Sachs, M.D.Topic -Dying from Dementia, Suffering Often Unneces...
Authors: Charytoniuk T, Małyszko M, Bączek J, Fiedorczyk P, Siedlaczek K, Małyszko J Abstract Nephrectomy, which constitutes a gold-standard procedure for the treatment of renal-cell carcinoma (RCC), has been widely discussed in the past decade as a significant risk factor of the development of chronic kidney disease (CKD). RCC is the third most common genitourinary cancer in the United States, with an estimated more than 65,000 new cases and 14,970 deaths. The aim of this review was to precisely and comprehensively summarize the status of current knowledge in chronic kidney disease risk factors after nephrectom...
No abstract available
Authors: Russo Picasso MF, Vicens J, Giuliani C, Jaén ADV, Cabezón C, Figari M, Gómez Saldaño AM, Figar S Abstract Background: Two hypotheses attempt to explain the increase of thyroid cancer (TC) incidence: overdetection by excessive diagnostic scrutiny and a true increase in new cases brought about by environmental factors. Changes in the mechanism of detection and the risk of incidentally diagnosed TC could result in an increase of TC incidence. Methods: Retrospective cohort study. We identified incident cases of TC from the pathological reports of patients in a HMO and review of ...
Contributors : Ting La ; Xu D ZhangSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Mus musculusTo investigate miRNAs in quiescent cancer cell
(MedPage Today) -- Also, breast-conserving surgery or mastectomy?
(Reuters Health) - People with diabetes are more likely to develop certain cancers than those without the condition, and a new analysis suggests that the increased risk is greater for women than for men.
Publication date: Available online 15 August 2018Source: SteroidsAuthor(s): Julius Fink, Masahito Matsumoto, Yoshifumi TamuraAbstractSedentary lifestyle and over-nutrition are the main causes of obesity and type 2 diabetes (T2D). However, the same causes are major triggers of hypogonadism. Many T2D patients show low testosterone levels while hypogonadal men seem to be prone to become diabetic. Testosterone plays a major role in the regulation of muscle mass, adipose tissue, inflammation and insulin sensitivity and is therefore indirectly regulating several metabolic pathways, while T2D is commonly triggered by insulin resi...
(Reuters Health) - Cancer patients who use alternative, non-medical therapies may be more likely to forgo recommended medical treatments like chemotherapy and radiation, and be more likely to die as a result, a U.S. study suggests.
The herbicide gyphosate is the world ’ s most popular weedkiller. There is widespread disagreement among lawyers, researchers and regulators over any potential links to cancer.
The now published results from the EMBRACA study confirm that talazoparib prolongs progression-free survival in advanced BCRA-positive breast cancer.Medscape Medical News
More News: Alzheimer's | Amnesia | Cancer | Cancer & Oncology | Cancer in Adolescents | Dementia | Emergency Medicine | Harvard | Health Management | IV Therapy | Learning | Nurses | Nursing | Pain | Palliative | Palliative Care | Parenteral Nutrition | Pneumonia | Pressure Sores | Study | Teaching | Universities & Medical Training | Urinary Tract Infections | USA Health